13
landing page
FasterCures
What We Do
FasterCures, a center of the Milken Institute, is working to build a system that is effe
ctive, efficient, and driven by a clear vision: patient needs above all else.
+ Read More
landing page
FasterCures Advisory Board
landing page
About TRAIN
, What is Venture Philanthropy?
Venture philanthropy is a concept very much in vogue but without
a commonly agreed-upon definition.
+ Read More
landing page
Foundation Company Partnership Toolkit
A growing number of foundations are providing funding to biotech and pharma companies to incentivize
research in their disease areas and help start-ups cross the 'Valley of Death'. Use the information in this toolkit
+ Read More
landing page
Foundation University Partnerships Toolkit
Foundations have a long tradition of supporting research conducted by academic institu
ti
+ Read More
landing page
Foundations as Collaboration Conveners Toolkit
Scientific research requires cross-sector, multi-disciplinary collaboration to make progress.
article
FasterCures Quarterly Update—July 2024
In This Newsletter
Highlights from Global Conference
Recent Publications
Policy Updates
FasterCures
Program Updates
+ Read More
landing page
Case Studies
FasterCures has often found models of medical research innovation outside of the traditional establi
shment, specifically at the nonprofit foundations that comprise The Research Acceleration and Innovation Network (TRAIN)., The Cystic Fibrosis Foundation
The Cystic Fibrosis Foundation (CFF) is recognized as one of the best examples of venture philanthropy in medical re
+ Read More
article
TRAIN Newsletter — July 2024
TRAIN eNews is delivered directly to organizations that take part in The Research Acceleration and I
nnovation Network (TRAIN).
+ Read More
article
An Update from MI Health—July 2024
In This Issue:
article
Milken Institute Statement on Newly Released FDA Guidance on Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Trials
The Milken Institute celebrates the publication of the second iteration of the Food and Drug Adminis
tration (FDA) draft guidance on Diversity Action Plans (DAP) to improve clinical trial diversity by enrolling underrepresented populations in the US.
+ Read More
article
Collecting and Sharing Patient Data: Guiding Principles, Governance, and Sustainability
Summary
Establishing and developing a data collection and management platform can be a central acti
vity for many patient foundations that have a mission to advance biomedical R&D.
+ Read More